公司資料
Omnicell 股價、新聞與催化劑
- 股票代碼:
- OMCL
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
36.03 USD (-3.40%)
收盤價
最後更新: 2026年8月17日
1.91B USD
市值
股價為何變動
As of Aug 17, 2026, OMCL closed down 3.40% at $36.03. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Omnicell is a healthcare technology company focused on medication-management automation and hospital workflow software.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Omnicell sits in healthcare IT and medtech infrastructure.
商業模式特徵
Revenue comes from automation hardware, software, and recurring services used by hospitals and health systems.
生技產業定位
Omnicell is not a biotech stock, but it is important to the healthcare stack because it helps manage medication use and workflow.
未來催化劑
- Omnicell's catalysts are XT automation adoption, hospital medication-management software, and the pace of product-cycle upgrades. The business matters most when the installed base keeps expanding and recurring software gets more embedded.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。